Bartlett & Co Wealth Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35
Closed -$802 1314
2025
Q1
$802 Buy
+35
New +$845 ﹤0.01% 1129
2023
Q4
Sell
-569
Closed -$21.1K 1269
2023
Q3
$21.1K Hold
569
﹤0.01% 816
2023
Q2
$22.2K Hold
569
﹤0.01% 805
2023
Q1
$20.8K Hold
569
﹤0.01% 704
2022
Q4
$17.5K Buy
+569
New +$17.7K ﹤0.01% 739

Other funds holding RTO

Bartlett & Co Wealth Management's RTO Position: Q2 2025 in Review

Bartlett & Co Wealth Management sold out of Rentokil (RTO) in Q2 2025, closing a stake of 35 shares — an estimated $802 sold.

Bartlett & Co Wealth Management first reported a position in RTO in Q4 2022 and held it in 5 quarters. The position peaked at $22.2K in Q2 2023. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • Bartlett & Co Wealth Management reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 35 Rentokil shares in Q2 2025, an estimated $802.
  • Bartlett & Co Wealth Management first reported a position in Rentokil in Q4 2022 and held it in 5 quarters.
  • Bartlett & Co Wealth Management's Rentokil position peaked at $22.2K in Q2 2023.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.